I agree with you, that it may be, that the benefits of vaccination outweigh risks, for population as a whole.
Please also narrow in to my actual point, which is that for large demographics, it’s not a good idea to now get double-vaccinated. Whereas, EAG recommends all attendees to get double vaccinated. (Or at least they did; they seem to have changed their wording just now as a result of this post.)
You want to talk about other demographics, or even the population as a whole? Let’s do it, as an additional topic. As I don’t see good risk-benefit analysis, with general background of natural immunity, etc, for other age groups. And am curious to know more. Although, again, this would be a separate topic from what I am stating above.
The countries that have advised against double-vaccination, in my link, were advising against Moderna, which indeed is an mrna vaccine. Think you need to click that link.
″ It slows down transmission ”—this was definitely true in the past. I’m not sure if someone with natural immunity (almost everyone), who now gets double-vaccinated, will be substantially slowing down transmission, over what they were already doing. Source needed.
“It also reduces severity of symptoms for those who are vaccinated and go get the virus”—even for the 90% of people who have natural immunity… the oldish formula, double-vaccination will do this today? I don’t disbelieve you. But again, source needed.
The booster article: I understand your point on mandate vs. recommendation. Mandates would certainly be much worse. The main point here is just that it’s probably wise to NOT mandate OR recommend, for all demographics.
I agree with you, that it may be, that the benefits of vaccination outweigh risks, for population as a whole.
Please also narrow in to my actual point, which is that for large demographics, it’s not a good idea to now get double-vaccinated. Whereas, EAG recommends all attendees to get double vaccinated. (Or at least they did; they seem to have changed their wording just now as a result of this post.)
You want to talk about other demographics, or even the population as a whole? Let’s do it, as an additional topic. As I don’t see good risk-benefit analysis, with general background of natural immunity, etc, for other age groups. And am curious to know more. Although, again, this would be a separate topic from what I am stating above.
The countries that have advised against double-vaccination, in my link, were advising against Moderna, which indeed is an mrna vaccine. Think you need to click that link.
″ It slows down transmission ”—this was definitely true in the past. I’m not sure if someone with natural immunity (almost everyone), who now gets double-vaccinated, will be substantially slowing down transmission, over what they were already doing. Source needed.
“It also reduces severity of symptoms for those who are vaccinated and go get the virus”—even for the 90% of people who have natural immunity… the oldish formula, double-vaccination will do this today? I don’t disbelieve you. But again, source needed.
The booster article: I understand your point on mandate vs. recommendation. Mandates would certainly be much worse. The main point here is just that it’s probably wise to NOT mandate OR recommend, for all demographics.